Molecular Assemblies Revenue and Competitors

Claim your profile

Location

#4134

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Molecular Assemblies's estimated annual revenue is currently $7.8M per year.(i)
  • Molecular Assemblies's estimated revenue per employee is $172,222
  • Molecular Assemblies's total funding is $61.2M.

Employee Data

  • Molecular Assemblies has 45 Employees.(i)
  • Molecular Assemblies grew their employee count by 32% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$27.4M146-5%$160MN/A
#2
$3.7M24N/AN/AN/A
#3
$18.1M93-3%$24.1MN/A
#4
$47.1M304-3%N/AN/A
#5
$48.1M28014%$403MN/A
#6
$459.2M206854%$242.6MN/A
#7
$0.9M14133%$6.1MN/A
#8
$14.9M79-12%$140MN/A
#9
$29M187-1%N/AN/A
#10
$3.7M24N/AN/AN/A

Molecular Assemblies, Inc. is a private biotechnology company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented enzymatic method, based on making DNA the way nature makes DNA, produces long, high-quality, sequence-specific DNA reliably, affordably, and sustainably. Molecular Assemblies’ technology will unleash a new generation of DNA synthesis for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines and bio-based electronics. Molecular Assemblies is headquartered in San Diego.

keywords:N/A

$61.2M

Total Funding

45

Number of Employees

$7.8M

Revenue (est)

32%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Molecular Assemblies News

2022-04-06 - Codexis and Molecular Assemblies Announce Results of First ...

Molecular Assemblies has pioneered Fully Enzymatic Synthesis™ (or FES™) technology with an in-process purification step to overcome the...

2022-04-06 - Codexis and Molecular Assemblies Announce Results of First ...

The Fully Enzymatic Synthesis technology developed by Molecular Assemblies employs a template-independent DNA polymerase, terminal...

2022-03-22 - Molecular Assemblies to Launch Enzymatic DNA Synthesis as ...

Since the 3' reversible terminator used in FES is only removable with an enzyme, he said, Molecular Assemblies scientists were able to devise a...

2021-04-15 - Molecular Assemblies Picks Up $24M For DNA Synthesis

San Diego-based Molecular Assemblies said this morning that it has raised $24M in a Series A funding round, which came from Agilent Technologies, iSelect Fund, Codexis, Alexandria Venture Investments, and Argonautic Ventures, as well as LYFE Capital. According to the company, it will use the fun ...

2021-04-15 - Molecular Assemblies Closes Oversubscribed $24 Million Series A Financing to Advance Enzymatic DNA Synthesis toward Initial Commercial Access

SAN DIEGO, April 15, 2021 /PRNewswire/ -- Molecular Assemblies, Inc., today announced that it has closed an oversubscribed $24 million Series A financing with significant investment from Agilent Technologies, iSelect Fund, Codexis, Alexandria Venture Investments, and Argonautic Ventures. In ad ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.2M45-6%N/A
#2
$7.6M450%N/A
#3
$9.9M45N/AN/A
#4
$12.2M45N/AN/A
#5
$9M45-6%N/A